Abnova Corp. (4133)

Overview

Abnova (Taiwan) Corporation was established in 2002 and is located in Taipei, Taiwan. It operates in the biotechnology sector, focusing on the manufacturing and distribution of various recombinant proteins and antibodies. The company is known for its comprehensive range of products catered to the scientific and pharmaceutical communities. Abnova aims to support academic and research institutions, along with pharmaceutical companies through their extensive portfolio. The company stands out for its integrated solutions and services that span from gene synthesis to assay development, providing a one-stop shop for research and development needs.

Products and Services

• SARS-CoV/CoV-2 DNA, RNA, Proteins/Peptides, Lysates/Slides: These products are designed for research on SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus) and SARS-CoV-2, the virus responsible for COVID-19. They are crucial for understanding the viral structure, replication mechanisms, and for developing diagnostic tools and vaccines.
• Ab Pairs/Kits, Ab Arrays: Antibody pairs for ELISA and antibody microarrays for profiling and discovery studies. These are essential tools in diagnostics, allowing for the simultaneous detection of multiple target antigens.
• Polclinic Antibody, Beads/Dyes: Polyclonal antibodies for various research applications, and beads/dyes that are used in experiments requiring cell sorting, tagging, or tracking.
• In Situ Hybridization Products, Systems, and Automations: Tools and systems designed for detecting and localizing specific DNA/RNA sequences in tissue sections or cell samples. These are vital for diagnosing genetic diseases and cancers.
• MaxPab, Monoclonal, Polyclonal, Recombinant, Conjugate, Secondary/Tag, IHC/Pathology, and Circulating Rare Cell Antibodies: A wide range of antibodies for different applications, including immunohistochemistry (IHC), pathology, and the detection of circulating rare cells, which is crucial for cancer research and diagnostics.
• Integrated Solutions and Services:
  • Gene Synthesis and Cytogenetics: Services supporting the custom synthesis of genes and the study of chromosomal structures and functions for genetic research and diagnostics.
  • Peptide Services, Protein Expression, and Conjugations: Custom peptide synthesis, protein production, and conjugation services for creating specific proteins or attaching molecules to proteins for research or therapeutic purposes.
  • Antibody Production: Custom production of monoclonal and polyclonal antibodies tailored to specific research or diagnostic needs.
  • Assay Development Services: Development of custom assays, including ELISA, for the detection of various biomolecules, critical in research, diagnostics, and drug development processes.